BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li DJ, Yue Q, Liu L, Che KK, Liu XM, Hu CH. Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats. Acta Pharmacol Sin 2021;42:1267-79. [PMID: 33976388 DOI: 10.1038/s41401-021-00680-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Wu Q, Zhou Y, Yu L, Yu L, Deng Y, Tu C, Li W. The mechanisms underlying olanzapine-induced insulin resistance via the brown adipose tissue and the therapy in rats. Adipocyte 2022;11:84-98. [PMID: 35067163 DOI: 10.1080/21623945.2022.2026590] [Reference Citation Analysis]
2 Horska K, Ruda-Kucerova J, Skrede S. GLP-1 agonists: superior for mind and body in antipsychotic-treated patients? Trends Endocrinol Metab 2022;33:628-38. [PMID: 35902330 DOI: 10.1016/j.tem.2022.06.005] [Reference Citation Analysis]
3 Zhang B, Yuan Y, Xin J, Chen M, Wang Z, Li X, Xue T, Sasaoka T. Study of Water- and Organic-Soluble Extracts from Trichosanthes on Type 1 Diabetes Mellitus. Journal of Diabetes Research 2022;2022:1-10. [DOI: 10.1155/2022/3250016] [Reference Citation Analysis]